Alessandro Salviati, MD PhD
Affiliations: | Neurology | University of Verona, Verona, WI, United States |
Google:
"Alessandro Salviati"Bio:
UNIVERSITA DI VERONA
INSTITUTO DI NEUROLOGICA
POLICLINICO DI BORGO ROMA
VERONA, 37134
Italy
Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Tonin R, Caciotti A, Procopio E, et al. (2019) Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content. Scientific Reports. 9: 17684 |
Simoncini C, Chico L, Concolino D, et al. (2016) Mitochondrial DNA haplogroups may influence Fabry disease phenotype Neuroscience Letters. 629: 58-61 |
Paraboschi EM, Rimoldi V, Soldà G, et al. (2014) Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. Human Molecular Genetics. 23: 6746-61 |
Mariotto S, Tamburin S, Salviati A, et al. (2014) Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. Case Reports in Neurology. 6: 38-43 |
Barizzone N, Pauwels I, Luciano B, et al. (2013) No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis. Annals of Neurology. 73: 433-7 |
Gajofatto A, Stefani A, Turatti M, et al. (2013) Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 697-703 |
Caciotti A, Garman SC, Rivera-Colón Y, et al. (2011) GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. Biochimica Et Biophysica Acta. 1812: 782-90 |
Salviati A, Burlina AP, Borsini W. (2010) Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 31: 299-306 |
Invernizzi P, Bonometti MA, Turri E, et al. (2008) A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1003-6 |
Mazzola S, Lira MG, Benedetti MD, et al. (2007) COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk. International Journal of Immunogenetics. 34: 71-4 |